University of Oklahoma Researchers Discover Dual Genetic Pathways Driving Heart Disease and Diabetes in South Asian Populations

University of Oklahoma study identifies two unique genetic pathways in Asian Indians that could lead to personalized treatments for cardiometabolic disease.

By: AXL Media

Published: Apr 24, 2026, 3:47 AM EDT

Source: Information for this report was sourced from University of Oklahoma

A Genomic Deep Dive into Lipid Metabolism

The pursuit of precision medicine has reached a new milestone with the identification of two distinct genetic pathways that regulate how the human body processes fats and their subsequent impact on heart health. Led by Dr. Dharambir Sanghera at the University of Oklahoma, the research team analyzed the "lipidome," the comprehensive range of fats in the body, to understand why certain populations are more prone to cardiometabolic conditions. Unlike the majority of genomic studies which rely on data from individuals of European descent, this project specifically examined Asian Indians, a demographic that faces a disproportionately high risk of early-onset heart disease and Type 2 diabetes.

The Discovery of Protective and Pathogenic Metabolites

Through a complex screening of 516 lipid metabolites in 3,000 individuals, the researchers isolated two specific molecules that play a direct role in disease progression. The first pathway involves a protective metabolite that was found to be significantly lower in patients suffering from heart disease. This discovery suggests a potential preventative strategy, as increasing this specific metabolite through nutritional intervention or pharmacological treatment could theoretically lower a patient's overall disease risk. The second identified pathway produces a metabolite that, when elevated, triggers systemic inflammation and drives insulin resistance, the primary precursor to diabetes.

Addressing the Diversity Gap in Medical Research

A significant driver of this study’s success was its focus on a historically underrepresented population in genetic research. Dr. Sanghera emphasized that the two critical genetic pathways would likely have remained hidden if the study had followed the traditional Eurocentric research model. By cross-referencing their findings with data from over one million Europeans and 15,000 individuals of Indian ancestry, the team was able to prove that genetic risk factors are not universal. This distinction is vital for the development of personalized medicine, as it highlights how ancestry and cultural backgrounds influence the biological "subtypes" of common diseases.